Tapentadol is a centrally acting opioid analgesic registered for use in Australia to treat moderate to severe pain. A recent review has suggested a lack of data regarding ‘abuse, dependence, diversion, or recreational use’ of tapentadol. This paper addresses this research gap by examining patterns of tapentadol use among a sentinel sample of people who regularly inject drugs in Australia.

Resources

Author(s)

Rachel Sutherland, Sonja Memedovic, Louisa Degenhardt, Michael Farrell & Amy Peacock
Date Commenced
30 May 2019
Resource Type
Drug Trends Bulletins